Lindsay Puckett, MD

Publications

• The Role of Mitochondrial Dysfunction in Radiation-Induced Heart Disease: From Bench to Bedside.

  (Livingston K, Schlaak RA, Puckett LL, Bergom C.) Front Cardiovasc Med. 2020;7:20 PMID: 32154269 PMCID: PMC7047199 03/11/2020

• A Survey Study of Female Radiation Oncology Residents' Experiences to Inform Change.

  (Osborn VW, Doke K, Griffith KA, Jones R, Lee A, Maquilan G, Masters AH, Albert AA, Dover LL, Puckett LL, Hentz C, Kahn JM, Colbert LE, Barry PN, Jagsi R.) Int J Radiat Oncol Biol Phys. 2019 08 01;104(5):999-1008 PMID: 31108141 SCOPUS ID: 2-s2.0-85067169791 05/21/2019

• #WomenWhoCurie: Leveraging Social Media to Promote Women in Radiation Oncology.

  (Albert AA, Knoll MA, Doke K, Masters A, Lee A, Dover L, Hentz C, Puckett L, Goodman CR, Osborn VW, Barry P, Jagsi R.) Adv Radiat Oncol. 2019 Apr-Jun;4(2):218-225 PMID: 31011664 PMCID: PMC6460226 04/24/2019

• Preventing Discontinuation of Radiation Therapy: Predictive Factors to Improve Patient Selection for Palliative Treatment.

  (Puckett LL, Luitweiler E, Potters L, Teckie S.) J Oncol Pract. 2017 09;13(9):e782-e791 PMID: 28759295 SCOPUS ID: 2-s2.0-85032433192 08/02/2017

• Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE.

  (Levy Barazany H, Barazany D, Puckett L, Blanga-Kanfi S, Borenstein-Auerbach N, Yang K, Peron JP, Weiner HL, Frenkel D.) Exp Neurol. 2014 May;255:63-70 PMID: 24552689 SCOPUS ID: 2-s2.0-84896301689 02/21/2014

• Five-year outcomes of squamous cell carcinoma of the tonsil treated with radiotherapy.

  (Mourad WF, Hu KS, Puckett L, Hauerstock D, Shourbaji RA, Li Z, Manolidis S, Schantz S, Tran T, Jacobson A, Urken M, Culliney B, Persky M, Harrison LB.) Am J Clin Oncol. 2014 Feb;37(1):57-62 PMID: 23357967 SCOPUS ID: 2-s2.0-84893802313 01/30/2013

• Scara1 deficiency impairs clearance of soluble amyloid-β by mononuclear phagocytes and accelerates Alzheimer's-like disease progression.

  (Frenkel D, Wilkinson K, Zhao L, Hickman SE, Means TK, Puckett L, Farfara D, Kingery ND, Weiner HL, El Khoury J.) Nat Commun. 2013;4:2030 PMID: 23799536 PMCID: PMC3702268 SCOPUS ID: 2-s2.0-84883361779 06/27/2013

• Case series analysis of post-brachytherapy prostate edema and its relevance to post-implant dosimetry. Post-implant prostate edema and dosimetry.

  (Tejwani A, Bieniek E, Puckett L, Lavaf A, Guirguis A, Bennish A, Ashamalla H.) J Contemp Brachytherapy. 2012 Jun;4(2):75-80 PMID: 23349648 PMCID: PMC3552628 01/26/2013

• Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36.

  (Means TK, Mylonakis E, Tampakakis E, Colvin RA, Seung E, Puckett L, Tai MF, Stewart CR, Pukkila-Worley R, Hickman SE, Moore KJ, Calderwood SB, Hacohen N, Luster AD, El Khoury J.) J Exp Med. 2009 Mar 16;206(3):637-53 PMID: 19237602 PMCID: PMC2699123 SCOPUS ID: 2-s2.0-63449138494 02/25/2009

• A nasal proteosome adjuvant activates microglia and prevents amyloid deposition.

  (Frenkel D, Puckett L, Petrovic S, Xia W, Chen G, Vega J, Dembinsky-Vaknin A, Shen J, Plante M, Burt DS, Weiner HL.) Ann Neurol. 2008 May;63(5):591-601 PMID: 18360829 PMCID: PMC2747093 SCOPUS ID: 2-s2.0-43949141594 03/25/2008

• Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis.

  (Basso AS, Frenkel D, Quintana FJ, Costa-Pinto FA, Petrovic-Stojkovic S, Puckett L, Monsonego A, Bar-Shir A, Engel Y, Gozin M, Weiner HL.) J Clin Invest. 2008 Apr;118(4):1532-43 PMID: 18340379 PMCID: PMC2267014 SCOPUS ID: 2-s2.0-41849124231 03/15/2008